The Current Ratio as of December 2025 (TTM) for Climb Bio, Inc. (CLYM) is 14.08

According to Climb Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.08. This represents a change of -52.05% compared to the average of 29.37 of the last 4 quarters.

Climb Bio, Inc. (CLYM) Historical Current Ratio (quarterly & annually)

How has CLYM Current Ratio performed in the past?

The mean historical Current Ratio of Climb Bio, Inc. over the last ten years is 25.22. The current 14.08 Current Ratio has changed 5.48% with respect to the historical average. Over the past ten years (40 quarters), CLYM's Current Ratio was at its highest in in the June 2024 quarter at 60.41. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Climb Bio, Inc. (CLYM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Climb Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Climb Bio, Inc. (CLYM) Average Current Ratio

How has CLYM Current Ratio performed in the past?

The current Current Ratio of Climb Bio, Inc. (CLYM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Climb Bio, Inc. (CLYM) Current Ratio vs. Peers

How is CLYM’s Current Ratio compared to its peers?

Climb Bio, Inc.’s Current Ratio is greater than Entera Bio Ltd. (10.83), greater than Spero Therapeutics, Inc. (3.83), greater than Seres Therapeutics, Inc. (2.30), greater than Anixa Biosciences, Inc. (8.45), greater than Acumen Pharmaceuticals, Inc. (6.02), greater than Inovio Pharmaceuticals, Inc. (1.66), greater than Actuate Therapeutics Inc (2.74), greater than Turn Therapeutics Inc. (3.20), greater than VistaGen Therapeutics, Inc. (5.79), greater than Agenus Inc. (0.06),

Build a custom stock screener for Climb Bio, Inc. (CLYM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Climb Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Climb Bio, Inc. (CLYM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Climb Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.